Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "Journal of Clinical Oncology"

Add to list
Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma : a BEACON-Neuroblastoma biomarker study

Lucas Moreno, Rebekah Weston, Virginie Viprey, Andrei Tchirkov, Maria Corrias, Tim Lammens (UGent) , Juliet Gray, Cormac Owens, Jennifer Laidler, Marion Gambart, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 40(supplement 16).
Add to list
- Journal Article
- A1
- open access
Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis

YX Gwee, Chia DKA, J So, Wim Ceelen (UGent) , WP Yong, P Tan, CJ Ong and R Sundar

(2022) JOURNAL OF CLINICAL ONCOLOGY. 40(24).
Add to list
- Conference Paper
- C3
A prospective phase I/IIa trial to evaluate the safety and efficacy of GTA002, an off-the-shelf, ex vivo-cultured allogeneic NK cell preparation in patients with acute myeloid leukemia in complete morphological remission who have measurable residual disease

Michael Heuser, Walter M. Fiedler, Tessa Kerre (UGent) , Johan Maertens, Jakob Passweg, Arjan Van De Loosdrecht, Antonia Maria Mueller, Jean-Henri Bourhis, Katarzyna Nowek, Jan Spanholtz, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 39(15).
Add to list
- Conference Paper
- C3
Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan Andreas Burger, Peter Hillmen, Steve E. Coutre, Stephen Devereux, Sebastian Grosicki, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 39(15).
Add to list
Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study

Wim Ceelen (UGent) , Louis Sandra (UGent) , Leen Van de Sande (UGent) , Martin Graversen, An Vermeulen (UGent) , Dries Reynders (UGent) , Sarah Cosyns (UGent) , Anne Hoorens (UGent) and Wouter Willaert (UGent)

(2021) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 39(Supplement 15). p.4065-4065
Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Journal Article
- A1
- open access
Glofitamab, a novel, bivalent CD20-targeting T-cell-engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma : a phase I trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmelo Carlo-Stella, Fritz Offner (UGent) , Anna Sureda, Gilles Salles, Joaquin Martinez-Lopez, Michael Crump, Denise N. Thomas, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(18). p.1959-1971
Add to list
- Conference Paper
- C3
Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer : preliminary results

Peter Van Dam, Yannick Verhoeven, Jorrit De Waele, Julie Jacobs, Pieter-Jan Van Dam, Mark Kockx, Koen Van de Vijver (UGent) , Martin Lammens, An Wouters, Evelien Smits, et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(15).
Add to list
- Conference Paper
- C3
Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).

Ben Tran, Lisa Horvath, Matthew Rettig, Karim Fizazi, Martijn P. Lolkema, Tanya B. Dorff, Richard Greil, Jean-Pascal H. Machiels, Karen A. Autio, Sylvie Rottey (UGent) , et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(15).
Add to list
- Journal Article
- A1
- open access
Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Keith Holmes, Ulrike Pötschger, Andrew D. J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas Matthyssens (UGent) , et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(25). p.2902-2916

Academic Bibliography

Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma : a BEACON-Neuroblastoma biomarker study

Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis

A prospective phase I/IIa trial to evaluate the safety and efficacy of GTA002, an off-the-shelf, ex vivo-cultured allogeneic NK cell preparation in patients with acute myeloid leukemia in complete morphological remission who have measurable residual disease

Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Glofitamab, a novel, bivalent CD20-targeting T-cell-engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma : a phase I trial

Uncovering the immune-modulating role of anti-RANKL therapy for cervical cancer : preliminary results

Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).

Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Contents

Support

Contact